Shared genetic background between children and adults with ADHD

Paula Rovira

Attention deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterized by age-inappropriate symptoms of inattention, impulsivity, and hyperactivity that persist into adulthood in the majority of the diagnosed children. Despite several risk factors during childhood predicting the persistence of ADHD symptoms into adulthood, the genetic architecture underlying the trajectory of ADHD over time is still unclear. We set out to study the contribution of common genetic variants to the risk for ADHD across the lifespan by conducting meta-analyses of genome-wide association studies on persistent ADHD in adults and ADHD in childhood separately and jointly, and by comparing the genetic background between them in a total sample of 17,149 cases and 32,411 controls. Our results show nine new independent loci and support a shared contribution of common genetic variants to ADHD in children and adults. No subgroup heterogeneity was observed among children, while this group consists of future remitting and persistent individuals. We report similar patterns of genetic correlation of ADHD with other ADHD-related datasets and different traits and disorders among adults, children, and when combining both groups. These findings confirm that persistent ADHD in adults is a neurodevelopmental disorder and extend the existing hypothesis of a shared genetic architecture underlying ADHD and different traits to a lifespan perspective.

Publication information

Title: Shared genetic background between children and adults with attention deficit/hyperactivity disorder

Authors: Paula Rovira, Ditte Demontis, Cristina Sánchez-Mora, Tetyana Zayats, Marieke Klein, Nina Roth Mota, Heike Weber, Iris Garcia-Martínez, Mireia Pagerols, Laura Vilar-Ribó, Lorena Arribas, Vanesa Richarte, Montserrat Corrales, Christian Fadeuilhe, Rosa Bosch, Gemma Español Martin, Peter Almos, Alysa E. Doyle, Eugenio Horacio Grevet, Oliver Grimm, Anne Halmøy, Martine Hoogman, Mara Hutz, Christian P. Jacob, Sarah Kittel-Schneider, Per M. Knappskog, Astri J. Lundervold, Olga Rivero, Diego Luiz Rovaris, Angelica Salatino-Oliveira, Bruna Santos da Silva, Evgeniy Svirin, Emma Sprooten, Tatyana Strekalova, ADHD Working Group of the Psychiatric Genomics Consortium, 23andMe Research team, Alejandro Arias-Vasquez, Edmund J. S. Sonuga-Barke, Philip Asherson, Claiton Henrique Dotto Bau, Jan K. Buitelaar, Bru Cormand, Stephen V. Faraone, Jan Haavik, Stefan E. Johansson, Jonna Kuntsi, Henrik Larsson, Klaus-Peter Lesch, Andreas Reif, Luis Augusto Rohde, Miquel Casas, Anders D. Børglum, Barbara Franke, Josep Antoni Ramos-Quiroga, María Soler Artigas & Marta Ribasés

Journal: Neuropschyopharmacology

Year: 2020

Url: https://doi.org/10.1038/s41386-020-0664-5